Explore Oahu During Your Conference Stay
When you’re ready for a break from 2024 Winter Clinical Dermatology Conference sessions, Oahu is ready for you with a range of island activities.
Read More
Author: Teresa Sellinger
Genomics Is a ‘Truly Powerful Tool’ for Changing Lung Cancer Outcomes
Given its potential to impact health, physicians should not hesitate to refer families with a strong history of cancer for genetic counseling and testing.
Read More
Q&A: Guidelines Focus on Geriatric Assessment for Older Adults Undergoing Cancer Therapy
Geriatric assessment is considered the standard of care for older adults starting systemic cancer therapy.
Read More
What Influences Physician Malpractice Insurance Rates?
No matter what, physicians must remember that quality malpractice insurance is never a substitute for superb medical care and risk management.
Read More
Drug-Resistant Epilepsy Impairs Psychological Well-Being
HRQoL among patients with drug-resistant epilepsy is affected by psychiatric conditions, impairments in activities of daily living, and more.
Read More
Medical Fiction: The Grinch & the Christmas Thief
The fictional story of Greg, an overzealous hospital loss prevention manager, facing a chaotic Christmas Eve after accusing a sly co-worker of theft.
Read More
How Will the Amazon Generation Change Healthcare?
The healthcare industry faces challenges in its attempts to meet the needs of patients who value...
Read More
Disorders & Diseases Associated With Childlessness Identified
Mental-behavioral disorders, congenital anomalies, and endocrine-nutritional-metabolic disorders are most strongly associated with childlessness.
Read More
Listen to Your Heart
“My mother told me to always listen to my heart.”
Read More
Why Physicians Need to Build Patient Trust to Obtain More Quality Digital Data
Healthcare providers need patient data to provide the best care; however, patients are increasingly weary of providing this data. Here’s how to build trust.
Read More
82% of Caregivers Say Tardive Dyskinesia Severely Impacts Patients
Tardive dyskinesia impacts both the patients living with the movement disorder and those who care for them.
Read More
Histochemical Kidney Analysis Suggests Potential Precision Therapy for Lupus Nephritis
This study pushes the field of rheumatology closer to precision medicine and away from a one-size-fits-all approach to treatment.
Read More
Meet the Trialist: Jeff Sharman, MD, on ELEVATE-TN
Treatment that includes acalabrutinib can improve progression-free survival in treatment-naïve patients with chronic lymphocytic leukemia.
Read More
Advancing to Phase 3 Designs for Advanced NSCLC
Dr. Reckamp co-authored a paper that addresses the need for cautious progression from phase 1 to phase 3 trials for advanced NSCLC, summarized here.
Read More
Age & Comorbidities Influence Early Mortality in Paroxysmal Nocturnal Hemoglobinuria
The most common causes of death in patients with paroxysmal nocturnal hemoglobinuria were cardiovascular disease and associated hematologic disease.
Read More
Brief Training Improves Counseling by Pediatricians on Social Media Safety
Training on social media safety for pediatricians improved rates of patient counseling on the topic and adolescents’ social media behavior.
Read More
Majority of Survivors of Breast Cancer Have Elevated Risk for ASCVD
Optimizing modifiable CVD risk factors management offers an opportunity to address the leading cause of noncancer mortality for survivors of breast cancer.
Read More
Should Doctorate Degree Nurse Practitioners Call Themselves “Doctors?”
Although many in the healthcare setting have earned a Dr. title, not all are MDs—leading to confused patients and, in some cases, fines and legal issues.
Read More
Liver Transplant Results Improve, but Re-Transplant Results Lag
Advances in knowledge and techniques improved postoperative liver transplant outcomes, but optimizing re-liver transplant outcomes requires further research.
Read More
Sandwich Treatment Model Shows Promise for Mantle Cell Lymphoma
A sandwich treatment model that includes acalabrutinib and rituximab in combination with R-DHAOx chemotherapy shows encouraging results in phase 2 trial.
Read More